Cite
Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
MLA
Agudelo, Maria, et al. “Nontherapeutic Equivalence of a Generic Product of Imipenem-Cilastatin Is Caused More by Chemical Instability of the Active Pharmaceutical Ingredient (Imipenem) than by Its Substandard Amount of Cilastatin.” PloS One, vol. 14, no. 2, Feb. 2019, p. e0211096. EBSCOhost, https://doi.org/10.1371/journal.pone.0211096.
APA
Agudelo, M., Rodriguez, C. A., Zuluaga, A. F., & Vesga, O. (2019). Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin. PloS One, 14(2), e0211096. https://doi.org/10.1371/journal.pone.0211096
Chicago
Agudelo, Maria, Carlos A Rodriguez, Andres F Zuluaga, and Omar Vesga. 2019. “Nontherapeutic Equivalence of a Generic Product of Imipenem-Cilastatin Is Caused More by Chemical Instability of the Active Pharmaceutical Ingredient (Imipenem) than by Its Substandard Amount of Cilastatin.” PloS One 14 (2): e0211096. doi:10.1371/journal.pone.0211096.